PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1215444
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1215444
Global Bone Cancer Treatment Market is valued at approximately USD 1.2 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2022-2029. Bone Cancer is a rare disease that affects bones. It begins with bones and can spread to other parts of the body and damages normal bone tissues. Osteosarcoma is considered the most common type of bone cancer that develops in the cells where new bone tissue forms. There are different treatment methods for bone cancer which include surgery, radiation therapy and chemotherapy. The increasing prevalence of bone cancer and growing penetration of cancer care services in developing regions as well as strategic initiatives from leading market players are key factors accelerating the market growth.
The increasing incidences of bone cancers are contributing to the growth of the Global Bone Cancer Treatment Market. For instance, according to American Cancer Society's estimates- in 2022, around 3910 new cases of bone cancer were reported in the United States, whereas approximately 2100 children & adults lost their lives due to bone cancer. Moreover, the most prevalent types of cancer in children and teens are Osteosarcoma with 56% prevalence, followed by Ewing tumors (34%), and Chondrosarcoma (6%). Also, growing government initiatives & reimbursement policies and rising healthcare infrastructure in developing regions would create a lucrative growth prospectus for the market over the forecast period. However, high treatment cost stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Bone Cancer Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of leading market players and increasing technological advancements in bone cancer treatment in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, increasing government spending on healthcare infrastructure and rising emergence of cancer care centers in the region.
Major market players included in this report are:
Advaxis Inc.
Takeda Pharmaceutical Company Limited
Cancervax, Inc
Cellectar Biosciences, Inc
Pfizer, Inc
Isofol Medical Ab
Gradalis Inc
Hikma Pharmaceutical PLC
QSAM Biosciences, Inc.
Zentalis Pharmaceuticals
Recent Developments in the Market:
Global Bone Cancer Treatment Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Type, Drug Type, Distribution Channel, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Osteosarcoma
Chondrosarcoma
Ewing Sarcoma
By Drug Type
Immunotherapy and Targeted Therapy
Chemotherapy
By Distribution Channel
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable